INNOVATOR ETFS TRUST - IBD 50 ETF (FFTY)

Historical Holders from Q1 2016 to Q3 2025

Symbol: FFTY
Type / Class: Equity / IBD 50 ETF
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 771,501
Holdings value: $28,336,849
% of all portfolios: 0%
Number of holders: 39
Number of buys: 19
Number of sells: -16
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of INNOVATOR ETFS TRUST - IBD 50 ETF (FFTY)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	771,501	$28,336,849	+$2,322,194	$616,440	$762,144	$37.36	39
2025 Q2	738,342	$24,033,932	+$1,601,519	$32,490	$805,752	$32.49	38
2025 Q1	711,486	$19,208,563	-$735,050	$37,758	$399,156	$26.97	38
2024 Q4	735,247	$21,073,102	-$1,493,952	$20,013	$60,039	$28.59	32
2024 Q3	759,820	$20,585,600	-$10,057,727	$64,560	$34,970	$26.9	29
2024 Q2	1,099,734	$30,406,966	-$685,275	$0	$8,331	$27.77	36
2024 Q1	1,126,602	$30,950,501	-$210,207	$13,820	$77,392	$27.64	38
2023 Q4	1,144,704	$27,961,901	-$244,674	$9,748	$43,866	$24.37	38
2023 Q3	1,157,590	$25,772,260	+$1,632,588	$44,756	$358,070	$22.38	40
2023 Q2	1,055,493	$26,951,353	+$5,641,954	$0	$0	$25.58	44
2023 Q1	842,780	$19,971,870	-$1,955,099	$68,564	$182,049	$23.64	46
2022 Q4	929,855	$20,637,601	-$5,834,526	$6,546	$85,098	$21.82	46
2022 Q3	1,026,144	$25,465,122	-$2,338,232		$0	$24.44	47
2022 Q2	1,116,996	$30,416,147	-$8,164,337	$0	$226,000	$26.85	54
2022 Q1	1,062,865	$41,539,413	-$6,868,372	$946,000	$735,000	$39.09	65
2021 Q4	1,536,651	$67,754,388	-$22,864,829	$339,000	$261,000	$45.84	76
2021 Q3	1,928,310	$92,331,739	+$26,262,217	$298,000	$1,918,000	$47.37	68
2021 Q2	1,376,724	$63,474,243	-$7,678,533	$760,000	$765,000	$46.35	67
2021 Q1	1,538,434	$68,486,867	+$16,012,209	$2,032,000	$597,000	$43.88	66
2020 Q4	1,201,575	$50,336,084	-$704,377		$427,000	$41.05	62
2020 Q3	1,226,876	$45,691,797	-$9,946,154	$0	$507,000	$37.3	59
2020 Q2	1,507,198	$52,258,064	-$4,649,386	$403,000	$1,009,000	$34.42	68
2020 Q1	1,556,171	$43,826,421	-$23,289,376	$778,000	$299,000	$27.99	62
2019 Q4	2,445,539	$85,227,293	-$15,565,273	$994,000		$34.73	79
2019 Q3	2,843,103	$91,851,404	-$19,823,073		$0	$32.27	69
2019 Q2	3,388,973	$116,339,480	-$21,650,663		$333,000	$34.29	81
2019 Q1	4,087,484	$137,066,137	+$40,062,028	$0	$231,000	$33.52	84
2018 Q4	2,907,064	$80,550,820	-$35,563,261	$325,000	$328,000	$27.62	79
2018 Q3	3,899,946	$149,841,944	+$36,077,307	$200,000	$423,000	$38.44	82
2018 Q2	3,063,863	$107,286,897	+$46,222,988	$4,000		$35.09	78
2018 Q1	1,710,898	$56,987,526	+$16,653,211	$3,000		$33.31	61
2017 Q4	1,211,115	$40,173,564	+$39,800,239			$33.18	41
2016 Q2	0	$0	-$1,477,000				0
2016 Q1	44,142	$1,477,000				$33.46	1